FMT
3 clinical trials
1 product
2 abstracts
6 indications
Indication
Functional Gastrointestinal DisordersIndication
FMTIndication
Crohn's DiseaseIndication
Inflammatory Bowel DiseaseIndication
MicrobiotaIndication
Clostridium difficile infectionAbstract
First-line treatment of fecal microbiota transplantation for immune-mediated colitis.Org: University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center,
Abstract
Immune checkpoint inhibitor-associated gastrointestinal adverse events in patients with colorectal cancer.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, The University of Texas Health Science Center at Houston,
Clinical trial
Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Functional Gastrointestinal Disorders in ChildrenStatus: Recruiting, Estimated PCD: 2026-08-01
Clinical trial
The MIRO II Study: Microbial Restoration in Inflammatory Bowel DiseasesStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Fecal Microbiota Transplantation Versus Standard Medical Therapy for Initial Treatment of Recurrent Clostridium Difficile InfectionStatus: Terminated, Estimated PCD: 2020-01-01
Product
FMT + anti-PD-1